Insider · CIK 0001442730

Geary Richard S

Reports to the SEC for 1 company · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001442730

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-11-06	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+14.7K sh	$56.78	+$837K	74,395
2025-11-06	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−14.7K sh	$76.10	−$1.12M	59,657
2025-11-06	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+18.3K sh	$60.89	+$1.11M	77,957
2025-11-06	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−18.3K sh	$75.42	−$1.38M	59,657
2025-11-06	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−14.7K sh	—	—	0
2025-11-06	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−18.3K sh	—	—	0
2025-11-05	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+800 sh	$56.78	+$45.4K	60,457
2025-11-05	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−800 sh	$75.01	−$60K	59,657
2025-11-05	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+801 sh	$60.89	+$48.8K	60,458
2025-11-05	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−801 sh	$75.01	−$60.1K	59,657
2025-11-05	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−800 sh	—	—	14,738
2025-11-05	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−801 sh	—	—	18,300
2025-11-03	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+775 sh	$60.89	+$47.2K	60,432
2025-11-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−775 sh	$75.05	−$58.2K	59,657
2025-11-03	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+905 sh	$56.78	+$51.4K	60,562
2025-11-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−905 sh	$75.05	−$67.9K	59,657
2025-11-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−905 sh	—	—	15,538
2025-11-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−775 sh	—	—	19,101
2025-11-03	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+775 sh	$56.78	+$44K	60,432
2025-11-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−775 sh	$75.05	−$58.2K	59,657
2025-11-03	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+905 sh	$60.89	+$55.1K	60,562
2025-11-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−905 sh	$75.05	−$67.9K	59,657
2025-11-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−775 sh	—	—	15,668
2025-11-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−905 sh	—	—	18,971
2025-10-31	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+34.6K sh	$60.89	+$2.11M	114,242
2025-10-31	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−34.6K sh	$75.11	−$2.6M	79,657
2025-10-31	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+34.7K sh	$56.78	+$1.97M	114,321
2025-10-31	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−34.7K sh	$75.11	−$2.6M	79,657
2025-10-31	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−20K sh	$75.11	−$1.5M	59,657
2025-10-31	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−34.7K sh	—	—	16,443
2025-10-31	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−34.6K sh	—	—	19,876
2025-09-30	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+57.9K sh	$53.77	+$3.11M	137,557
2025-09-30	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−57.9K sh	$65.24	−$3.78M	79,657
2025-09-30	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−57.9K sh	—	—	0
2025-09-02	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−10K sh	$50.37	−$504K	79,657
2025-08-29	IONSIONIS PHARMACEUTICALS INCJ Other	EVP, Chief Development Officer	JOther	+165 sh	$27.71	+$4,572.15	89,657
2025-08-05	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−10K sh	$42.86	−$429K	89,492
2025-02-28	IONSIONIS PHARMACEUTICALS INCJ Other	EVP, Chief Development Officer	JOther	+415 sh	$28.21	+$11.7K	99,492
2025-01-31	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−1,406 sh	$32.40	−$45.6K	99,077
2025-01-30	IONSIONIS PHARMACEUTICALS INCA Award	EVP, Chief Development Officer	AAward	+3,820 sh	—	—	100,483
2025-01-16	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−7,072 sh	$32.86	−$232K	96,663
2025-01-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+18.9K sh	—	—	103,735
2025-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP, Chief Development Officer	AAward	+22K sh	—	—	64,801
2025-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP, Chief Development Officer	AAward	+33K sh	—	—	79,625
2025-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−18.9K sh	—	—	60,724
2025-01-02	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP, Chief Development Officer	AAward	+22K sh	—	—	22,000
2024-08-30	IONSIONIS PHARMACEUTICALS INCJ Other	EVP, Chief Development Officer	JOther	+11 sh	$38.64	+$425.051	84,834
2024-08-29	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−331 sh	$49.63	−$16.4K	84,823
2024-08-28	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−320 sh	$49.16	−$15.7K	85,154
2024-08-05	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Development Officer	SSale	−2,430 sh	$48.00	−$117K	85,508

Recent filings

Accepted (ET)
Nov 74
Geary Richard S0000874015-25-000277
SEC(opens sec.gov)
Nov 74/A
Geary Richard S0000874015-25-000276
SEC(opens sec.gov)
Nov 34
Geary Richard S0000874015-25-000270
SEC(opens sec.gov)

Companies

IONIS PHARMACEUTICALS INCEVP, Chief Development OfficerIONS

Address

C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD

CARLSBAD, CA, 92008